Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Michael Abrams
Payers
CMS rule gives Part D plans new negotiation tools
Part D plans will have new weapons to negotiate with drug companies, but experts question whether consumers will reap the benefits.
Robert King
Feb 12, 2020 4:54pm
Medicare trustees: Hospital fund set to run out by 2026
Apr 22, 2019 4:34pm
Adoption of risk-based models has stalled: survey
Mar 18, 2019 6:05pm
Benefits for providers, patients in new price transparency rule
Jan 4, 2019 7:15am
What the 2018 midterms mean for healthcare: predictability
Nov 8, 2018 7:30am
CMS' push for prices in drug ads facing a likely legal fight
Oct 16, 2018 4:57pm
